A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L. Cottrell, Angela D. M. Kashuba, Evan S. Dellon et al.|The Journal of Infectious Diseases|2016Cited by 303
A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/RitonavirJulie B. Dumond, Angela D. M. Kashuba, Manoli Vourvahis et al.|Clinical Pharmacology & Therapeutics|2010Cited by 63
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignMackenzie L. Cottrell, Angela D. M. Kashuba, Heather M. A. Prince et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 22
Predicting Effective Truvada <sup>®</sup> PrEP Dosing Strategies With a Novel PK-PD Model Incorporating Tissue Active Metabolites and Endogenous Nucleotides (EN)Mackenzie L. Cottrell, Angela D. M. Kashuba, Kuo H. Yang et al.|AIDS Research and Human Retroviruses|2014Cited by 12
Effect of HIV Infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital TractMackenzie L. Cottrell, Angela D. M. Kashuba, Kristine B. Patterson et al.|Antiviral Therapy|2014Cited by 7